ABVC BioPharma, Inc.

Healthcare · Biotechnology · United States

Last price 1 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 25.96M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

ABVC BioPharma, Inc., a clinical-stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which is in Phase II clinical trials as a combination therapy for triple negative breast cancer; ABV-1504, which has completed Phase II clinical trials for depressive disorders; ABV-1505, which is in Phase II clinical trials for adult attention deficit hyperactivity disorder; ABV-1702, which is in Phase II clinical trials to treat myelodysplastic syndromes; ...